Odovtos - International Journal of Dental Sciences ISSN Impreso: 1659-1046 ISSN electrónico: 2215-3411

OAI: https://revistas.ucr.ac.cr/index.php/Odontos/oai
Assessment of Electromyography in Evaluating Masseter Muscle Activity in Oral Submucous Fibrosis with Different Treatment Modalities: a Systematic Review


Oral submucous fibrosis; Electromyography; Masseter muscle.
Fibrosis submucosa oral; Electromiografía; Músculo masetero.

How to Cite

P., P., & T.N., U. M. (2023). Assessment of Electromyography in Evaluating Masseter Muscle Activity in Oral Submucous Fibrosis with Different Treatment Modalities: a Systematic Review. Odovtos - International Journal of Dental Sciences, 25(2), 10–19. https://doi.org/10.15517/ijds.2023.54119


Electromyography (EMG) is used for the measurement of muscle activity to characterize the nature of muscle contraction in Oral submucous fibrosis (OSMF).

Aim:  To assess the efficacy of EMG in evaluating masseter muscle activity in the management of OSMF. This review identified 73 records from standard databases which were rigorously screened with eligibility criteria and 3 clinical studies were identified based on our inclusion criteria. The quality of included studies was assessed by the PEDro scale and data was synthesized with detailed characterization. The Risk of Bias assessment among studies was done using the ROBINS-I tool and a meta-analysis could not be done due to high clinical heterogeneity. Our result recommends that EMG be used as an objective prognosis assessment tool by quantifying the management of OSMF irrespective of the intervention applied. However, it is not to be considered the gold standard as of now with limited data pooled and needs to be further assessed with clinical trials.  EMG can be advocated as a reliable adjunct assessment for measuring the interventional outcome of OSMF irrespective of treatment modalities.



Cox S.C., Walker D.M. Oral submucous fibrosis. A review. Australian Dental Journal 1996; 41: 294-9.

Tak J., Gupta N., Bali R. Oral Submucous Fibrosis: A Review Article on Etiopathogenesis. Kathmandu University Medical Journal 2015; 12: 153-6.

Rao N.R., Villa A., More C.B., Jayasinghe R.D., Kerr A.R., Johnson N.W. Oral submucous fibrosis: a contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management. J Otolaryngol Head Neck Surg 2020; 49: 3.

Bari S., Metgud R., Vyas Z., Tak A. An update on studies on etiological factors, disease progression, and malignant transformation in oral submucous fibrosis. J Cancer Res Ther 2017; 13: 399-405.

Pant I., Rao S.G., Kondaiah P. Role of areca nut induced JNK/ATF2/Jun axis in the activation of TGF-β pathway in precancerous Oral Submucous Fibrosis. Sci Rep 2016; 6: 34314.

Cui L., Cai X., Huang J., Li H., Yao Z. Molecular mechanism of Oral Submucous Fibrosis Induced by Arecoline: A literature review. J Clin Diagn Res 2020; 14 (7): ZE01-ZE05.

Iqbal A., Tamgadge S., Tamgadge A., Pereira T., Kumar S., Acharya S., et al. Evaluation of Ki-67 Expression in Oral Submucous Fibrosis and Its Correlation with Clinical and Histopathological Features. J Microsc Ultrastruct 2020; 8: 20-4.

Binnie W.H., Cawson R.A. A new ultrastructural finding in oral submucous fibrosis. Br J Dermatol 1972; 86: 286-90.

el-Labban N.G., Canniff J.P. Ultrastructural findings of muscle degeneration in oral submucous fibrosis. J Oral Pathol 1985; 14: 709-17.

Chawla H., Urs A-B., Augustine J., Kumar P. Characterization of muscle alteration in oral submucous fibrosis-seeking new evidence. Med Oral Patol Oral Cir Bucal 2015; 20: e670-7.

Chakarvarty A., Panat S.R., Sangamesh N.C., Aggarwal A., Jha P.C. Evaluation of masseter muscle hypertrophy in oral submucous fibrosis patients -an ultrasonographic study. J Clin Diagn Res 2014; 8: ZC45-7.

Basmajian J.V., De Luca C.J. Muscles Alive: Their Functions Revealed by Electromyography. Williams & Wilkins; 1985.

Turker H., Sze H. Surface Electromyography in Sports and Exercise. Electrodiagnosis in New Frontiers of Clinical Research 2013.

Placzek J.D., Boyce D.A. Orthopaedic Physical Therapy Secrets - E-Book. Elsevier Health Sciences; 2016.

Molnar C., Gair J. Concepts of biology, 1st Canadian edition 2015.

Kuo I.Y., Ehrlich B.E. Signaling in muscle contraction. Cold Spring Harb Perspect Biol 2015; 7: a006023.

Fryer G., Bird M., Robbins B., Fossum C., Johnson J.C. Resting Electromyographic Activity of Deep Thoracic Transversospinalis Muscles Identified as Abnormal With Palpation. Int J Osteopath Med 2010; 110: 61-8.

Moruzzi G. The electrophysiological work of Carlo Matteucci. 1964. Brain Res Bull 1996; 40: 69-91.

Wan J-J., Qin Z., Wang P-Y., Sun Y., Liu X. Muscle fatigue: general understanding and treatment. Exp Mol Med 2017; 49: e384.

Encyclopedia of the Neurological Sciences 2014.

De Luca C.J. Physiology and mathematics of myoelectric signals. IEEE Trans Biomed Eng 1979; 26: 313-25.

Kutz M. Biomedical Engineering and Design Handbook, Volume 2: Volume 2: Biomedical Engineering Applications. McGraw Hill Professional; 2009.

PROSPERO n.d. https://www.crd.york.ac.uk/prospero/ (accessed July 23, 2022).

Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 2021;10: 89.

Clinimetrics: Physiotherapy Evidence Database (PEDro) Scale. J Physiother 2020; 66: 59.

Sandercock P. The authors say: “The data are not so robust because of heterogeneity” - so, how should I deal with this systematic review? Meta-analysis and the clinician. Cerebrovasc Dis 2011;31: 615-20.

Ioannidis J.P.A., Patsopoulos N.A., Rothstein H.R. Reasons or excuses for avoiding meta-analysis in forest plots. BMJ 2008; 336: 1413-5.

Sterne J.A., Hernán M.A., Reeves B.C., Savović J., Berkman N.D., Viswanathan M., et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016; 355: i4919.

Kant P., Bhowate R.R., Sharda N. Assessment of cross-sectional thickness and activity of masseter, anterior temporalis and orbicularis oris muscles in oral submucous fibrosis patients and healthy controls: an ultrasonography and electromyography study. Dentomaxillofac Radiol 2014; 43: 20130016.

Sinha G., Sharma M.L., Ram C.S. An electromyographic evaluation of orbicularis oris and masseter muscle in pretreatment and posttreatment patients of oral submucous fibrosis: A prospective study. J Indian Acad Oral Med Radiol 2018; 30: 210.

Shandilya S., Mohanty S., Sharma P., Chaudhary Z., Kohli S., Kumar R.D. Effect of botulinum toxin-A on pain and mouth opening following surgical intervention in oral submucous fibrosis - A controlled clinical trial. J Craniomaxillofac Surg 2021; 49: 675-81.

Kebede B., Megersa S. Idiopathic masseter muscle hypertrophy. Ethiop J Health Sci 2011; 21: 209-12.

Jian C., Wei M., Luo J., Lin J., Zeng W., Huang W., et al. Multiparameter Electromyography Analysis of the Masticatory Muscle Activities in Patients with Brainstem Stroke at Different Head Positions. Front Neurol 2017; 0. https://doi.org/10.3389/fneur.2017.00221

Szyszka-Sommerfeld L., Machoy M., Lipski M., Woźniak K. The Diagnostic Value of Electromyography in Identifying Patients With Pain-Related Temporomandibular Disorders. Front Neurol 2019; 10: 180.

Szyszka-Sommerfeld L., Machoy M., Lipski M., Woźniak K. Electromyography as a Means of Assessing Masticatory Muscle Activity in Patients with Pain-Related Temporomandibular Disorders. Pain Res Manag 2020; 2020: 9750915.


Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Copyright (c) 2023 CC-BY-NC-SA 4.0


Download data is not yet available.